Role of helicobacter pylori CagA molecular variations in induction of host phenotypes with carcinogenic potential

Journal of Infectious Diseases

Volumn 199, Issue 8, 2009, Pages 1218-1221

  Schneider, Natasha ^a   Krishna, Uma ^a   Judith, Romero Gallo ^a   Israel, Dawn A ^a   Piazuelo, M Blanca ^a   Camargo, M Constanza ^a   Sicinschi, Liviu A ^a   Schneider, Barbara G ^a   Correa, Pelayo ^a   Peek Jr , Richard M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; INTERLEUKIN 8;

ARTICLE; CANCER RISK; CARCINOGENIC ACTIVITY; CONTROLLED STUDY; GENETIC VARIABILITY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN VARIANT;

AMINO ACID MOTIFS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CARCINOMA; CELL LINE; COLOMBIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; PHENOTYPE; PHOSPHORYLATION; PROTEIN ISOFORMS; RISK FACTORS; STOMACH NEOPLASMS; TENNESSEE;

EID: 65749113027     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597416     Document Type: Article

References (15)

1. Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Rev Cancer 2002; 2:28-37.
2. Wessler S, Backert S. Molecular mechanisms of epithelial-barrier disruption by Helicobacter pylori. Trends Microbiol 2008; 16:397-405.
3. Higashi H, Tsutsumi R, Fujita A, et al.Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 2002; 99:14428-33.
4. Yamaoka Y, El-Zimaity HM, Gutierrez O, et al.Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 1999; 117:342-9.
5. Azuma T, Yamakawa A, Yamazaki S, et al.Correlation between variation of the 3' region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J Infect Dis 2002; 186:1621-30.
6. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004; 127:514-23.
7. Rota CA, Pereira-Lima JC, Blaya C, Nardi NB. Consensus and variable region PCR analysis of Helicobacter pylori 3' region of cagA gene in isolates from individuals with or without peptic ulcer. J Clin Microbiol 2001; 39:606-12.
8. Argent RH, Hale JL, El-Omar EM, Atherton JC. Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J Med Microbiol 2008; 57:1062-7.
9. Bravo LE, van Doorn LJ, Realpe JL, Correa P. Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma? Am J Gastroenterol 2002; 97:2839-42.
10. Peek RM Jr, Blaser MJ, Mays DJ, et al.Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res 1999; 59:6124-31.
11. Pineros M, Ferlay J, Murillo R. Cancer incidence estimates at the national and district levels in Colombia. Salud Publica Mex 2006; 48:455-65.
12. Tennessee Cancer Registry. Total cancer cases and age-adjusted cancer incidence rates, stomach, 1999-2003. Available at: http://health.state.tn.us/ TCR. Accessed 20 October 2008.
13. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis. Am J Surg Pathol 1996; 20:1161-81.
14. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008; 134:306-23.
15. Franco AT, Israel DA, Washington MK, et al.Activation of -catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A 2005; 102: 10646-51.